Novartis AG (XSWX:NOVN) Total Assets : CHF83,825 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Novartis AG Total Assets?

Novartis AG's Total Assets for the quarter that ended in Mar. 2024 was CHF83,825 Mil.

During the past 12 months, Novartis AG's average Total Assets Growth Rate was -18.70% per year. During the past 3 years, the average Total Assets Growth Rate was -10.40% per year. During the past 5 years, the average Total Assets Growth Rate was -8.80% per year. During the past 10 years, the average Total Assets Growth Rate was -3.30% per year.

During the past 13 years, Novartis AG's highest 3-Year average Total Assets Growth Rate was 17.10%. The lowest was -10.40%. And the median was 3.40%.

Total Assets is connected with ROA %. Novartis AG's annualized ROA % for the quarter that ended in Mar. 2024 was 11.22%. Total Assets is also linked to Revenue through Asset Turnover. Novartis AG's Asset Turnover for the quarter that ended in Mar. 2024 was 0.13.

Novartis AG Total Assets Historical Data

The historical data trend for Novartis AG's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Total Assets Chart

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

116,310.36

113,517.98

121,383.20

109,419.22

86,432.44

Novartis AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															103,879.05	99,925.49	101,382.22	86,432.44	83,825.19

Novartis AG Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Novartis AG's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	40429.4	+	46003.036
	=	86,432

Novartis AG's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	35327.182	+	48498.011
	=	83,825

Novartis AG (XSWX:NOVN) Total Assets Explanation

Total Assets is connected with ROA %.

Novartis AG's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	9554.228	/	( (86432.436	+	83825.192)	/ 2 )
	=	9554.228	/	85128.814
	=	11.22 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Novartis AG's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	10769.832	/	( (86432.436	+	83825.192)	/ 2 )
=	10769.832	/	85128.814
=	0.13

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Novartis AG Total Assets Related Terms

Thank you for viewing the detailed overview of Novartis AG's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (XSWX:NOVN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (XSWX:NOVN) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOVNEE:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Novartis AG (XSWX:NOVN) Headlines

No Headlines